Caux, F., Patsatsi, A., Karakioulaki, M., Antiga, E., Baselga, E., Borradori, L., Caproni, M., Cardones, A. R., Chandran, N. S., Dräger, S., Drenovska, K., Goebeler, M., Günther, C., Hofmann, S. C., Ioannides, D., Joly, P., Marinović, B., Mariotti, E. B., Marzano, A. V., … Schmidt, E. (2024). S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology and Venereology, 38(6), 1006–1023. Portico. https://doi.org/10.1111/jdv.19880

Kang, J., Park, J., Jo, H., Lee, H., Lee, K., Kim, S., Kang, J., Lee, J. H., Papadopoulos, N. G., Lee, S., Shin, J.-Y., Rahmati, M., Cho, S. H., Cho, J. K., Lee, S., Pizzol, D., Yeo, S. G., Lee, H., Jin, S.-P., & Yon, D. K. (2024). Global Burden of Vaccine-Associated Chronic Urticaria, 2010–2023: From the Global Pharmacovigilance Database. Allergy, Asthma & Immunology Research, 16(6), 613. https://doi.org/10.4168/aair.2024.16.6.613

Gotlib, J., Castells, M., Elberink, H. O., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Heaney, M., Van Daele, P., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., … Maurer, M. (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evidence, 2(6). https://doi.org/10.1056/evidoa2200339

Youssef, S., Gallitano, S., & Bordone, L. A. (2023). Two cases of bullous pemphigoid effectively treated with oral tofacitinib. JAAD Case Reports, 32, 77–80. https://doi.org/10.1016/j.jdcr.2022.10.028